Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059234) titled 'Single-center prospective observational study investigating the impact of beta1 adrenergic receptor and its auto-antibody on responsiveness of beta-blocker in heart failure therapy' on Sept. 29.
Study Type: Observational
Study Design:
Not selected Not selected
Primary Sponsor: Hamamatsu University School of Medicine
Condition:
heart failure
Recruitment Status: Recruiting
Phase: Not selected
Date of First Enrollment: 2024/08/01
Target Sample Size: 100
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067752
Published by HT D...